Tag Archives:

Cetuximab en el tratamiento de cancer colo-rectal

Background Cetuximab, an IgG1 chimeric monoclonal antibody against epidermal growth factor receptor (EGFR), has activity against colorectal cancers that express EGFR. Methods From December 2003 to August 2005, 572 patients who had colorectal cancer expressing immunohistochemically detectable EGFR and who … Continue reading

Posted in Cancer, Medicamentos | Tagged , , , , , | Leave a comment